YK-4-279

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameYK-4-279
Drug Alias NameYK-4-279
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEWS-Fli1 protein inhibitors
TargetsEWS-Fli1 protein
Therapy Area/IndicationsSarcoma, Ewing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGeorgetown University (The)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGeorgetown University (The)
Active IndicationsN/A
Inactive IndicationsSarcoma, Ewing

Other Information

ATC CodeN/A
Related LinksN/A